Methionine, N-[[4-(2-chlorophenoxy)phenyl]sulfonyl]-

Catalog No. :
ACOJCD047
CAS No. :
1009715-74-5
Molecular Formula :
C17H18ClNO5S2
Molecular Weight :
415.92

IUPAC Name:((4-(2-chlorophenoxy)phenyl)sulfonyl)-L-methionine

Methionine, N-[[4-(2-chlorophenoxy)phenyl]sulfonyl]- structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
100mg95%$91.00Login to see priceIn stockInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product NameMethionine, N-[[4-(2-chlorophenoxy)phenyl]sulfonyl]-
IUPAC Name((4-(2-chlorophenoxy)phenyl)sulfonyl)-L-methionine
MDL No.MFCD03619097
Molecular FormulaC17H18ClNO5S2
Molecular Weight415.92
SMILESCSCC[C@H](NS(=O)(=O)C1=CC=C(OC2=CC=CC=C2Cl)C=C1)C(=O)O
InChI KeyVVLBKESFOSFQRN-HNNXBMFYSA-N
SynonymN-[4-(2-Chlorophenoxy)phenylsulfonyl]-S-MethylhoMocysteine, 96%;N-[4-(2-Chlorophenoxy)phenylsulfonyl]-S-Methyl-DL-hoMocysteine, 96%;((4-(2-Chlorophenoxy)phenyl)sulfonyl)methionine;Methionine, N-[[4-(2-chlorophenoxy)phenyl]sulfonyl]-;2-[[4-(2-Chlorophenoxy)phenyl]sulfonylamino]-4-methylsulfanylbutanoic acid
CAS No.1009715-74-5

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P301+P312-P302+P352-P304+P340-P305+P351+P338-P330-P332+P313-P337+P313-P362-P403+P233-P405-P501

Synthetic Route by SureRoute

1. ACOJCD047 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACOJCD047 route product structure diagram
    ACOJCD0471009715-74-5 In Stock
Inquiry

2. ACOJCD047 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACOJCD047 route product structure diagram
    ACOJCD0471009715-74-5 In Stock
Inquiry

Comments (0)